Le Lézard
Classified in: Science and technology
Subject: ACC

Bell Canada announces redemption price for Series M-36 debentures due April 2018


MONTRÉAL, Oct. 4, 2017 /CNW Telbec/ - Bell Canada announced on September 29, 2017 that it would redeem effective on October 9, 2017 (the "Redemption Date"), prior to maturity, all of its outstanding $300 million principal amount of 4.88% Debentures, Series M-36, due April 26, 2018 (the "Series M-36 Debentures"). Today, Bell Canada has determined the redemption price payable for the Series M-36 Debentures according to the terms of such debentures.

The redemption price for the Series M-36 Debentures must be equal to the greater of the "Canada Yield Price" and the principal amount of the Series M-36 Debentures, together in each case with accrued and unpaid interest up to, but excluding, the Redemption Date. The "Canada Yield Price", calculated today in accordance with the terms of the Series M-36 Debentures, is $1,017.480 per $1,000 of principal amount. Accordingly, the Series M-36 Debentures will be redeemed effective on the Redemption Date at a price equal to $1,017.480 per $1,000 of principal amount of debentures plus $22.241 per $1,000 of principal amount comprised of accrued and unpaid interest up to, but excluding, the Redemption Date and interest for the October 9, 2017 banking holiday in Canada at the Government of Canada Yield (as determined under the terms of the Series M-36 Debentures) plus 0.46%. The redemption price and interest will be paid on October 10, 2017.

About Bell

Bell is Canada's largest communications company, providing broadband wireless, TV, Internet and business communication services from Bell Canada, Bell Aliant and Bell MTS. Bell Media is Canada's premier multimedia company with leading assets in television, radio, out of home and digital media. To learn more, please visit Bell.ca or BCE.ca.

The Bell Let's Talk initiative promotes Canadian mental health with national awareness and anti-stigma campaigns like Bell Let's Talk Day, and provides significant Bell funding of mental health care and access, research and workplace leadership initiatives. To learn more, please visit Bell.ca/LetsTalk.

Media inquiries:

Jean Charles Robillard
514-870-4739
[email protected]

Investor inquiries:

Thane Fotopoulos
514-870-4619
[email protected]

 

SOURCE Bell Canada


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 18:57
Tribe Property Technologies Inc. (the "Issuer" or the "Company") , a leading provider of technology-elevated property management solutions, today announced that it expects to complete and file its 2023 Annual Filings (as defined below) on or before...

at 18:47
The Korean Cultural Center New York (KCCNY), a branch of the Ministry of Culture, Sports and Tourism of the Republic of Korea, is proud to present a special exhibition "Whanki in New York," from May 2 to June 13, 2024. This exhibition commemorates...



News published on and distributed by: